Elizabeth J. Shpall, MD, professor, deputy department chair, Department of Stem Cell Transplantation, Division of Cancer Medicine, medical director, Cell Therapy Laboratory, director, Cord Blood Bank, the University of Texas MD Anderson Cancer Center, discusses idelalisib and ibrutinib for the treatment of patients with chronic lymphocytic leukemia (CLL).
- See more at: onclive.com/onclive-tv/dr-s...
Jeff
venetoclax and obinutuzumab treatment for cll
CLL treatments in France
atypical CLL treatment 
CLL diagnosis with Obinutuzumab and Ventoclax offered as treatment
CLL Treatment concerns 
